Skip over main navigation
  • Sign up
  • Log in
  • Basket: (0 items)
Hepatitis Australia
Listen
  • Search
  • Instagram
  • Twitter
  • Facebook
  • YouTube
Info line  Donate
Menu
  • About us
    • Who we are
    • Our Team
    • Our Board
    • Our Members
    • Corporate documents
    • Our website
    • Contacting Us
  • Hepatitis information
    • Liver Health
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
    • Hepatitis Statistics
    • Other Languages
  • How to get help
    • COVID-19
    • Hepatitis Infoline
    • Your Rights and Responsibilities
    • For friends and family
    • Local hepatitis organisations
  • Get involved
    • Donate
    • Share your story
  • Our work
    • Hepatitis B Program
    • Hepatitis C Program
    • Policy and Advocacy
    • Our publications
    • World Hepatitis Day
    • If tatts could talk
  • News
    • Latest News
    • Media Releases
  • Workforce
    • Community
    • Professionals
    • Training Opportunities
  • Admin
    • Log in
  • Basket: (0 items)
  1. Workforce
  2. Professionals

COVID-19

Information for people affected by hepatitis B or C

Download this Factsheet

What is COVID-19?

COVID-19 is caused by a new strain of coronavirus that was first reported in December 2019.1 Coronaviruses are a family of viruses that can make humans and animals sick.

For the most current and free advice on COVID-19 please visit the national healthdirect website.

How do you get COVID-19?

The virus causing COVID-19 can be spread from person-to-person through:

  • close contact[i] with someone who has the virus, which includes:
    • contact with droplets from an infected person’s cough or sneeze
    • touching objects or surfaces that have cough or sneeze droplets from an infected person, then touching your face.2

Protecting against COVID-19

The latest information advises that good hygiene and social distancing are the best ways to protect against COVID-19, including:

  • washing your hands often and thoroughly with soap and water
  • covering your mouth with your elbow or a tissue if you cough or sneeze – throw the tissue away and wash your hands immediately
  • avoiding touching your face
  • avoiding close contact with people who have a fever or cough
  • staying home if you are unwell
  • cleaning and disinfecting surfaces
  • minimising physical contact with other people, including sexual contact with casual partners
  • keeping a distance of 1.5 metres between you and other people whenever possible
  • avoiding large public gatherings.2

The use of surgical masks is only recommended if you already have the virus to reduce you spreading it to others, or if you are caring for someone who has COVID-19.

If you are well, you do not need to wear a surgical mask. Reducing physical contact is more important.
You can find out more about surgical masks in this factsheet from the Department of Health. 

Symptoms of COVID-19

The virus will affect individuals differently. Most people who come in contact with the virus will experience a mild illness but can still spread the virus to others.

Some people can go on to develop serious effects such as pneumonia – people at particular risk of severe disease are listed on the next page. People with COVID-19 most commonly experience:

  • fever
  • flu-like symptoms, including coughing, sore throat and fatigue
  • shortness of breath.2

If you have a fever, cough or other symptoms, seek medical advice early. If you think you could have contracted COVID-19, you should call ahead before visiting a doctor.

If you have serious symptoms such as difficulty breathing, call 000 for urgent medical help.

Heathdirect Symptom Checker

What are the risks of COVID-19 for people living with hepatitis B or hepatitis C?

The following groups could be at higher risk of serious illness from COVID-19:2

  • people with weakened immune systems
    (e.g. people on immune suppressing medications, people receiving cancer treatments)
  • older people – the risk being much greater for people aged over 70 years
  • Aboriginal and Torres Strait Islander people
  • people with chronic medical conditions.

At this stage there is no evidence to suggest people living with hepatitis B or hepatitis C, who are well are at greater risk of infection with COVID-19.3 However, current information suggests some people living with hepatitis B and hepatitis C who also have other conditions such as hypertension, cardiovascular disease and diabetes will likely have an increased risk of serious illness if they get COVID-19.3

People who have developed advanced liver diseases (including cirrhosis) and deteriorating health as a result of hepatitis B or C should be vigilant in protecting themselves from contracting COVID-19 as they are at risk of more serious illness. This includes people who have ongoing health conditions as a result of a previous hepatitis C infection which has been cured.

Will COVID-19 mean any change to treatment and care for hepatitis B or hepatitis C

People living with hepatitis B or C who are currently taking treatment should not change or stop their treatment unless advised to do so by their treating doctor.  People should be aware that recent changes restricting prescriptions to a one-month supply of medications means ensuring you plan and avoid missing doses. There is nothing to suggest that the availability of medications used for hepatitis B or C will be reduced due to COVID-19.

Monitoring your health will continue to be important and access to doctors may vary. Some clinics are establishing telephone consultations but making appointments in advance will be important. You should check with your healthcare provider to see what arrangements they are putting in place. If you have an appointment with your doctor it is good to consider asking your doctor for a liver health check if you have not had one in the last six months.

What can you do to protect yourself if you have hepatitis B or hepatitis C?

People living with hepatitis B or C should use the same protective measures recommended for the general population. Be vigilant and follow the recommended measures to protect yourself against COVID-19. Consult a healthcare provider if in doubt about your risk, especially if you have been around someone who has recently returned from overseas.

People with significant liver disease are recommended to receive vaccinations against influenza and pneumococcal disease. These are funded for people aged 65 and over, and the influenza vaccine is funded for all people with chronic liver disease. Cigarette smoking also increases the risk of severe respiratory illness, and quitting smoking may reduce your chances of complications due to COVID-19.

What should you do if you care for someone who has a chronic health condition or compromised immune system?

If you’re caring for a person who has a chronic health condition or compromised immune system, it’s important to take extra care with handwashing and infection precautions. If you are unwell in any way, it is best to avoid contact with the person while you are unwell.

Providing practical support to people who at higher risk of COVID-19, such as assisting with shopping, collect prescriptions or other errands can also be helpful,.

Check that you have a plan in place to seek help if you or the person you are caring for become unwell. This may include checking in with them more regularly, having access to a phone and important phone numbers handy and ensuring medications are accessible.

Where can you get more information about COVID-19?

You can get additional information about the coronavirus on the healthdirect website: www.healthdirect.gov.au/coronavirus


[i] Close contact includes face-to-face contact, being in an enclosed space with someone for an extended period of time, or contact with a person’s blood or bodily fluids.

References:

  1. Department of Health. (2020, March 17). Coronavirus (COVID-19). Retrieved from Australian Government Department of Health: health.gov.au/health-topics/novel-coronavirus-2019-ncov [Accessed 18 March 2020]
  2. Department of Health. (2020, March 17). What you need to know about coronavirus (COVID-19). Retrieved from Australian Government Department of Health: health.gov.au/news/health-alerts/novel-coronavirus-2019-ncov-health-alert/what-you-need-to-know-about-coronavirus-covid-19#protect-yourself-and-others [Accessed 18 March 2020]
  3. (2020, March 19). COVID-19 BBV and STI Sector Briefing Webinar. Retrieved from ASHM: https://www.ashm.org.au/covid-19/ [Accessed 19 March 2020]

This factsheet was reviewed by the Doherty Institute on 6 March 2020 and updated by Hepatitis Australia on 20 March 2020 following the BBV/STI sector briefing on COVID-19. Hepatitis Australia encourages all readers to seek independent medical advice.

Published: 1st January, 2020

Updated: 14th October, 2020

Author: Grace Hogan

Related topics:
  • Professional workforce
Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Parliamentary Morning Tea: We can eliminate hepatitis C!

    Parliamentary Morning Tea: We can eliminate hepatitis C!

    The Parliamentary Friends Group for Action of Blood Borne Viruses Co-Chairs, Tim Wilson, MP and Senator Louise Pratt invite you to a Parliamentary Morning Tea on Thursday 12 November.

  • Renewed calls for Needle & Syringe Programs in prisons ahead of International Drug Users Day

    Renewed calls for Needle & Syringe Programs in prisons ahead of International Drug Users Day

    The Australian Injecting and Illicit Drug Users League (AIVL) and Hepatitis Australia are highlighting international calls for Needle and Syringe Programs (NSPs) in prisons, along with a greater focus on harm reduction initiatives, ahead of International Drug Users Day on 1 November.

  • Investment in hepatitis research needs to be accompanied by National Strategy implementation funding

    Investment in hepatitis research needs to be accompanied by National Strategy implementation funding

    6 October 2020 - Hepatitis Australia welcomes the Australian Government’s commitment to diverse hepatitis research, however we remain concerned that the 2019 Health Budget funding for hepatitis commitments is yet to hit the ground.

  • Investment in liver cancer medicines matched with prevention are changing Australian lives

    Investment in liver cancer medicines matched with prevention are changing Australian lives

    6 October 2020 - Hepatitis Australia welcomes the Australian Government’s significant investment of $230 million to expand the listing of Tecentriq® and Avastin® (atezolizumab and bevacizumab) on the Pharmaceutical Benefits Scheme (PBS).

Related

  • Hepatitis B Guide

    Hepatitis B Guide

    Testing, treatment and staying healthy. This guide is to help you understand the process from being tested for hepatitis B (often called hep B) to living well with chronic (life-long) hep B.

  • Hepatitis C Guides

    Hepatitis C Guides

    Testing and treating hepatitis C: Information for GPs and patients. Download these pdf resources specific to doctors and patients. Most patients with hep C can now be safely managed and cured in primary care.

  • Clinical guidelines

    Clinical guidelines

    Australian guidelines for the testing and treatment of hepatitis B and hepatitis C

  • Mental Health Worker Information

    Mental Health Worker Information

    Information to support people working in mental health services when discussing hepatitis C.

  • Contact tracing in regional and remote areas

    Contact tracing in regional and remote areas

    This video is designed for health workers, especially those working closely with regional and remote Aboriginal and Torres Strait Islander communities.

  • Taskforce on BBVs, Sexual Health and COVID-19

    Taskforce on BBVs, Sexual Health and COVID-19

    The BBV and sexual health sector taskforce discusses the scientific, clinical, BBV and sexual health service delivery and social implications of COVID-19, and provides consistent and evidence-based messaging to the health workforce, sector partners and community.

  • Eliminating Hepatitis

    Eliminating Hepatitis

    Resources to assist with achieving international goals to eliminate Viral Hepatitis by 2030.

  • Other Languages

    Other Languages

    Hepatitis Australia resources translated into various languages

  • Hepatitis Statistics

    Hepatitis Statistics

    A summary of the latest surveillance data for hepatitis B and C in Australia.

  • National Strategies

    National Strategies

    Links to Australia's National Hepatitis Strategies 2018 2022

Most read

  • Coronavirus COVID-19 factsheet for people with hepatitis B and hepatitis C

    Coronavirus COVID-19 factsheet for people with hepatitis B and hepatitis C

    Hepatitis Australia has put together a brief factsheet with information about the coronavirus COVID-19 for people living with hepatitis B and hepatitis C.

  • COVID-19

    COVID-19

    Information on the coronavirus COVID-19 for people affected by hepatitis B or hepatitis C.

  • Hepatitis A

    Basic information about hepatitis A in Australia

  • A cure for hepatitis C

    A cure for hepatitis C

    New highly effective medicines are now available in Australia to cure hepatitis C

  • Hepatitis B and relationships

    Hepatitis B and relationships

    Although most people get hepatitis B at birth, it can be transmitted in other ways including sex. This article contains information about how it is spreads, and how you can keep your partner safe.

  • Hepatitis B treatment

    Hepatitis B treatment

    Who needs treatment for hepatitis B and what is involved.

  • What is hepatitis C?

    What is hepatitis C?

    Basic information about hepatitis C and how it can effect you.

  • Hepatitis B vaccination

    Hepatitis B vaccination

    Hepatitis B can be prevented with a safe and effective vaccine.

  • Changes to immigration health requirement a positive move for migrants with hepatitis B

    Changes to immigration health requirement a positive move for migrants with hepatitis B

    21 August 2019 - Changes to the immigration health requirement will have a significant and positive impact for people with hepatitis B seeking to migrate permanently to Australia.

  • What is hepatitis B?

    What is hepatitis B?

    Basic information about hepatitis B transmission and how it affects people.

Join our mailing list

Interests

Info

Hepatitis Australia is a registered charity. 
ABN: 38 442 686 487

© Copyright 2019 Hepatitis Australia.
All rights reserved.
View our copyright statement here

Helpful links

  • Contact us
  • Full sitemap
  • Accessibillity
  • Terms & conditions
  • Privacy policy
  • Login
  • Logout
  • Manager

Member sites

  • Australian Capital Territory
  • New South Wales
  • Northern Territory
  • South Australia
  • Victoria
  • Queensland
  • Western Australia
  • Tasmania 

Information provided on this website is for general information only and not intended as medical advice. Hepatitis Australia encourages all readers to seek independent medical advice before making any decisions based on the information provided on this website.

Hepatitis Australia is a partner organisation of healthdirect Australia.
healthdirect - trusted health advice

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information: verify here.
Search only trustworthy HONcode health websites: 

Images used on this site may include stock photos and the associated messaging may not represent the personal situation, views or beliefs of the people in the images.